tm logo
AVEKTRUS
Live/Registered
REGISTERED

on 30 Apr 2024

Last Applicant/ Owned by

Bybrook Rd, Porton Down, Salisbury

Wiltshire

GB

SP40BF

Serial Number

97623312 filed on 07th Oct 2022

Registration Number

7370920 registered on 30th Apr 2024

in the Principal Register

Correspondent Address

Janet P. Peyton MCGUIREWOODS LLP

800 EAST CANAL STREET

RICHMOND, VA 23219

UNITED STATES

Filing Basis

1. intent to use

Disclaimer

NO DATA

AVEKTRUS

Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kalRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat; Pharmaceutical preparations for containing feniralstat(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat for the treatment of angioedema, hereditary angioedema, bradykinin mediated inflammatory disorders, plasma kallikrein or factor XIIa mediated diseases or disorders, or diseases and disorders mediated by the contact activation system


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Mark Details


Serial Number

No 97623312

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2051953-0003

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Apr 2024REGISTERED-PRINCIPAL REGISTER
30th Apr 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13th Feb 2024PUBLISHED FOR OPPOSITION
24th Jan 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11th Jan 2024APPROVED FOR PUB - PRINCIPAL REGISTER
11th Jan 2024EXAMINER'S AMENDMENT ENTERED
11th Jan 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11th Jan 2024EXAMINERS AMENDMENT E-MAILED
11th Jan 2024EXAMINERS AMENDMENT -WRITTEN